The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Sarena Francis Willard since 2016.
The trader's CIK number is 1423786.
At the time of the last reporting, Sarena Francis Willard was the Chief Strategy Officer of Five Prime Therapeutics, Inc.. (stock ticker symbol FPRX).
Also see all insider trading activities at Five Prime Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | FPRX | 0 | $0 | 0 | $0 | 44,000 | $0 |
| 2017 | FPRX | 0 | $0 | 3,636 | $172,310 | 3,636 | $20,143 |
| 2016 | FPRX | 0 | $0 | 76,364 | $3,654,550 | 76,364 | $578,034 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-11 | FPRX | Option Ex | 22,000 | .00 | 0 |
| 2020-11-11 | FPRX | Option Ex | 22,000 | .00 | 0 |
| 2017-01-18 | FPRX | Option Ex | 3,636 | 5.54 | 20,143 |
| 2017-01-18 | FPRX | Sale | 3,636 | 47.39 | 172,310 |
| 2016-11-28 | FPRX | Sale | 1,710 | 60.14 | 102,839 |
| 2016-11-28 | FPRX | Option Ex | 1,710 | 5.54 | 9,473 |
| 2016-11-23 | FPRX | Option Ex | 13,465 | 6.89 | 92,773 |
| 2016-11-23 | FPRX | Sale | 13,465 | 60.23 | 810,996 |
| 2016-11-25 | FPRX | Option Ex | 21,189 | 6.21 | 131,689 |
| 2016-11-25 | FPRX | Sale | 21,189 | 60.48 | 1,281,510 |
| 2016-03-29 | FPRX | Option Ex | 4,450 | 8.49 | 37,780 |
| 2016-03-30 | FPRX | Option Ex | 5,550 | 8.49 | 47,119 |
| 2016-03-29 | FPRX | Sale | 4,450 | 40.00 | 178,000 |
| 2016-03-30 | FPRX | Sale | 5,550 | 40.01 | 222,055 |
| 2016-01-27 | FPRX | Option Ex | 30,000 | 8.64 | 259,200 |
| 2016-01-27 | FPRX | Sale | 30,000 | 35.30 | 1,059,150 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sarena Francis Willard (Chief Strategy Officer of Five Prime Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.